A Two-part, Single Centre, Open-label, Randomised, Single Dose, Two-period, Crossover, Relative Bioavailability Study of Infacort® Versus Cortef® in Dexamethasone-suppressed Healthy Adult Male and Female Subjects in the Fasted and Fed States
Phase of Trial: Phase I
Latest Information Update: 17 Aug 2018
At a glance
- Drugs Hydrocortisone (Primary)
- Indications Adrenal insufficiency; Congenital adrenal hyperplasia
- Focus Pharmacokinetics
- Sponsors Diurnal
- 31 Aug 2018 Biomarkers information updated
- 07 Aug 2018 Status changed from recruiting to completed.
- 14 May 2018 Planned number of patients changed from 24 to 48.